Does DURVALUMAB Cause Myositis? 121 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 121 reports of Myositis have been filed in association with DURVALUMAB (IMFINZI). This represents 0.7% of all adverse event reports for DURVALUMAB.
121
Reports of Myositis with DURVALUMAB
0.7%
of all DURVALUMAB reports
39
Deaths
67
Hospitalizations
How Dangerous Is Myositis From DURVALUMAB?
Of the 121 reports, 39 (32.2%) resulted in death, 67 (55.4%) required hospitalization, and 32 (26.4%) were considered life-threatening.
Is Myositis Listed in the Official Label?
Yes, Myositis is listed as a known adverse reaction in the official FDA drug label for DURVALUMAB.
What Other Side Effects Does DURVALUMAB Cause?
Death (2,817)
Malignant neoplasm progression (1,330)
Pneumonitis (827)
Radiation pneumonitis (786)
Pyrexia (573)
Diarrhoea (530)
Pneumonia (453)
Dyspnoea (444)
Interstitial lung disease (430)
Off label use (395)
What Other Drugs Cause Myositis?
NIVOLUMAB (682)
PEMBROLIZUMAB (596)
ATORVASTATIN (448)
METHOTREXATE (418)
PREDNISONE (369)
RITUXIMAB (355)
ADALIMUMAB (344)
IPILIMUMAB (305)
ATEZOLIZUMAB (249)
INFLIXIMAB (249)
Which DURVALUMAB Alternatives Have Lower Myositis Risk?
DURVALUMAB vs DUTASTERIDE
DURVALUMAB vs DUTASTERIDE\TAMSULOSIN
DURVALUMAB vs DUVELISIB
DURVALUMAB vs DYDROGESTERONE
DURVALUMAB vs EBASTINE